Michael Christopher Risk

1.5k citations
42 papers · 1.2k · h-index 17

Impact in

  • Urology top 5%
    • Urinary Bladder and Prostate Research
    • Prostate Cancer Treatment and Research
    • Prostate Cancer Diagnosis and Treatment
    • Renal cell carcinoma treatment

Papers in

    • Prostate Cancer Diagnosis and Treatment 9
    • Prostate Cancer Treatment and Research 5
    • Renal cell carcinoma treatment 3
    • Bladder and Urothelial Cancer Treatments 9
    • Testicular diseases and treatments 4
    • Urinary and Genital Oncology Studies 3

Michael Christopher Risk

38 papers receiving 1.2k citations

Peers

Michael Christopher Risk
Comparison fields: 5 of 92
  • Urology 102
  • Pulmonary and Respiratory Medicine 442
  • Cancer Research 127
  • Molecular Biology 408
  • Oncology 135
Replace Daryle J. DePianto with:
Daryle J. DePianto United States
Chengliu Jin United States
Zuocheng Yang China
Ruifa Han China
Merja Bläuer Finland
Hirohiko Fujii Japan
Claire Bardel France
Fábio Albuquerque Marchi Brazil
Vijayalakshmi Ananthanarayanan United States
Xiangming Mao China
Michael Christopher Risk relative to Daryle J. DePianto United States Daryle J. DePianto's profile →
Citations per field
00.5×1.5×2.2×
Daryle J. DePianto · 1×
Citations per year

Countries citing papers authored by Michael Christopher Risk

Since Specialization
Citations

This map shows the geographic impact of Michael Christopher Risk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Christopher Risk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Christopher Risk more than expected).

Fields of papers citing papers by Michael Christopher Risk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Christopher Risk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Christopher Risk. The network helps show where Michael Christopher Risk may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Christopher Risk, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Christopher Risk Line = papers co-authored together Michael Christopher Risk links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2008241
2 2008220
3 199695
4 200962
5 201657
6 201046
7 201740
8 199840
9 200139
10 201938
11 201336
12 201524
13
The role of immunotherapy in prostate cancer: an overview of current approaches in development.
200922
14 201821
15 201821
16 201820
17 201918
18
Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay.
201815
19 200915
20
Newer Medications for Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Review
201614

About Michael Christopher Risk

Michael Christopher Risk is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Urology, Endocrinology, Diabetes and Metabolism and Immunology, having authored 42 papers that have together received 1.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (9 papers), Prostate Cancer Treatment and Research (5 papers), Urinary Bladder and Prostate Research (4 papers), Testicular diseases and treatments (4 papers), Renal cell carcinoma treatment (3 papers), Sexual function and dysfunction studies (3 papers) and Urinary and Genital Oncology Studies (3 papers). The work is most often cited by research in Urology (102 citations), Pulmonary and Respiratory Medicine (442 citations), Cancer Research (127 citations), Molecular Biology (408 citations) and Oncology (135 citations). Michael Christopher Risk has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include Ilsa Coleman, Peter Nelson, Lawrence True, Philipp Dahm, Valeri I. Vasioukhin, Olga Klezovitch, Jared M. Lucas, Geula Gibori, Laura E. Pascal and Lillian J. Eichner. Their work appears in journals such as Cochrane Database of Systematic Reviews, The Journal of Urology, World Journal of Urology, Endocrinology and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact